Cell lineage and cell death: Caenorhabditis elegans and cancer research

Nature Reviews Cancer

Volumn 11, Issue 1, 2011, Pages 50-58

  Potts, Malia B ^a   Cameron, Scott ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; EGG LAYING DEFECTIVE 1; HOMEODOMAIN PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; CAENORHABDITIS ELEGANS; CANCER RESEARCH; CANCER THERAPY; CELL DEATH; CELL FATE; CELL LINEAGE; CELL SURVIVAL; DNA DAMAGE; HOX GENE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 78650602309     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2984     Document Type: Review

References (129)

1. White, K. et al. Genetic control of programmed cell death in Drosophila. Science 264, 677-683 (1994).
2. Ellis, H. M. & Horvitz, H. R. Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817-829 (1986).
3. Yin, C, Knudson, C. M., Korsmeyer, S. J. & Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640 (1997).
4. Sulston, J. E. & Horvitz, H. R. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol. 56, 110-156 (1977).
5. Sulston, J. E., Schierenberg, E., White, J. G. & Thomson, J. N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100, 64-119 (1983).
6. Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
7. Zarkower, D. Somatic sex determination. WormBook [online], http://www.wormbook.org/chapters/www-somaticsexdeterm/somaticsexdeterm.html (2007).
8. Cameron, S., Clark, S. G., McDermott, J. B., Aamodt, E. & Horvitz, H. R. PAG-3, a Zn-finger transcription factor, determines neuroblast fate in C. elegans. Development 129, 1763-1774 (2002).
9. Jia, Y., Xie, G., McDermott, J. B. & Aamodt, E. The C. elegans gene pag-3 is homologous to the zinc finger proto-oncogene gfi-1. Development 124, 2063-2073 (1997).
10. Hock, H. et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002-1007 (2004).
11. Hock, H. et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 18, 109-120 (2003).
12. Saleque, S., Cameron, S. & Orkin, S. H. The zinc-finger proto-oncogene Gfi-1 b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 16, 301-306 (2002).
13. Wu, M. et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell 1, 541-554 (2007).
14. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. & Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 (3-converting enzyme. Cell 75, 641-652 (1993). (Pubitemid 23346363)
15. Yuan, J. Y & Horvitz, H. R. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev. Biol. 138, 33-41 (1990).
16. Hengartner, M. O., Ellis, R. E. & Horvitz, H. R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494-499 (1992).
17. Hengartner, M. O. & Horvitz, H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76, 665-676 (1994).
18. Conradt, B. & Horvitz, H. R. The TRA-1A sex determination protein of C. elegans regulates sexually dimorphic cell deaths by repressing the egl-1 cell death activator gene. Cell 98, 317-327 (1999).
19. Conradt, B. & Horvitz, H. R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-529 (1998).
20. Horvitz, H. R. Worms, life, and death (Nobel lecture). Chembiochem 4, 697-711 (2003).
21. Vaux, D. L, Weissman, I. L. & Kim, S. K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258, 1955-1957 (1992).
22. Vaux, D. L, Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442 (1988).
23. Zinkel, S. S. et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev. 17, 229-239 (2003).
24. Ranger, A. M. et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 100, 9324-9329 (2003).
25. Yan, N. et al. Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 437, 831-837 (2005).
26. Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413 (1997).
27. Zou, H., Li, Y., Liu, X. & Wang, X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556 (1999).
28. Oberst, A., Bender, C. & Green, D. R. Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 15, 1139-1146 (2008).
29. Orme, M. & Meier, P. Inhibitor of apoptosis proteins in Drosophila: gatekeepers of death. Apoptosis 14, 950-960 (2009).
30. Goyal, L. Cell death inhibition: keeping caspases in check. Cell 104, 805-808 (2001).
31. Maurer, C. W., Chiorazzi, M. & Shaham, S. Timing of the onset of a developmental cell death is controlled by transcriptional induction of the C. elegans ced-3 caspase-encoding gene. Development 134, 1357-1368 (2007).
32. Park, D., Jia, H., Rajakumar, V. & Chamberlin, H. M. Pax2/5/8 proteins promote cell survival in C. elegans. Development 133, 4193-4202 (2006).
33. Nehme, R. et al. Transcriptional upregulation of both egl-1 BH3-only and ced-3 caspase is required for the death of the male-specific CEM neurons. Cell Death Differ. 17, 1266-1276 (2010).
34. Ellis, R. E. & Horvitz, H. R. Two C. elegans genes control the programmed deaths of specific cells in the pharynx. Development 11 2, 591-603 (1991).
35. Metzstein, M. M., Hengartner, M. O., Tsung, N., Ellis, R. E. & Horvitz, H. R. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 382, 545-547 (1996).
36. Metzstein, M. M. & Horvitz, H. R. The C. elegans cell death specification gene ces-1 encodes a snail family zinc finger protein. Mol. Cell 4, 309-319 (1999).
37. Thellmann, M., Hatzold, J. & Conradt, B. The Snail-like CES-1 protein of C. elegans can block the expression of the BH3-only cell-death activator gene egl-1 by antagonizing the function of bHLH proteins. Development 130, 4057-4071 (2003).
38. Inaba, T. et al. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382, 541-544 (1996).
39. Inaba, T. et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257, 531-534 (1992).
40. Hunger, S. P. et al. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 77, 687-693 (1991).
41. Hemavathy, K., Guru, S. C., Harris, J., Chen, J. D. & Ip, Y. T. Human Slug is a repressor that localizes to sites of active transcription. Mol. Cell. Biol. 20, 5087-5095 (2000).
42. Inukai, T. et al. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol. Cell 4, 343-352 (1999).
43. Wu, W. S. et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123, 641-653 (2005).
44. Hatzold, J. & Conradt, B. Control of apoptosis by asymmetric cell division. PLoS Biol. 6, e84 (2008).
45. Buchman, J. J. & Tsai, L. H. Spindle regulation in neural precursors of flies and mammals. Nature Rev. Neurosci. 8, 89-100 (2007).
46. Neumuller, R. A. & Knoblich, J. A. Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer. Genes Dev. 23, 2675-2699 (2009).
47. Ellis, R. & Schedl, T. Sex determination in the germ line. WormBook [online], http://www.wormbook.org/ chapters/www-sexgermline/sexgermline.html (2007).
48. Hodgkin, J. A. & Brenner, S. Mutations causing transformation of sexual phenotype in the nematode Caenorhabditis elegans. Genetics 86, 275-287 (1977).
49. Peden, E., Kimberly, E., Gengyo-Ando, K., Mitani, S. & Xue, D. Control of sex-specific apoptosis in C. elegans by the BarH homeodomain protein CEH-30 and the transcriptional repressor UNC-37/Groucho. Genes Dev. 21, 3195-3207 (2007).
50. Schwartz, H. T. & Horvitz, H. R. The C. elegans protein CEH-30 protects male-specific neurons from apoptosis independently of the Bcl-2 homolog CED-9. Genes Dev. 21, 3181-3194 (2007).
51. Collum, R. G. et al. A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system. Nucleic Acids Res. 20, 4919-4925 (1992).
52. Gidekel, S., Pizov, G., Bergman, Y. & Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361-370 (2003).
53. Budhram-Mahadeo, V. S. & Latchman, D. S. Targeting Brn-3b in breast cancer therapy. Expert Opin. Ther. Targets 10, 15-25 (2006).
54. Eisen, T., Easty, D. J., Bennett, D. C. & Goding, C. R. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 11, 2157-2164 (1995).
55. Shin, S. H. et al. Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knockdown analysis. Exp. Mol. Med. 40, 229-236 (2008).
56. Buscarlet, M. & Stifani, S. The 'Marx' of Groucho on development and disease. Trends Cell Biol. 17, 353-361 (2007).
57. Shah, N. et al. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. Eur. J. Cancer 44, 2144-2151 (2008).
58. Zarkower, D. & Hodgkin, J. Molecular analysis of the C. elegans sex-determining gene tra-1: a gene encoding two zinc finger proteins. Cell 70, 237-249 (1992).
59. Yauch, R. L. et al. A paracrine requirement for hedgehog signalling in cancer. Nature 455, 406-410 (2008).
60. Dierks, C. et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nature Med. 13, 944-951 (2007).
61. Regl, G. et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64, 7724-7731 (2004).
62. Bigelow, R. L. et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J. Biol. Chem. 279, 1197-1205 (2004).
63. Hirose, T., Galvin, B. D. & Horvitz, H. R. Six and Eya promote apoptosis through direct transcriptional activation of the proapoptotic BH3-only gene egl-1 in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 107, 15479-15484 (2010).
64. Christensen, K. L., Patrick, A. N., McCoy, E. L. & Ford, H. L. The six family of homeobox genes in development and cancer. Adv. Cancer Res. 101, 93-126 (2008).
65. Clark, S. G., Chisholm, A. D. & Horvitz, H. R. Control of cell fates in the central body region of C. elegans by the homeobox gene lin-39. Cell 74, 43-55 (1993).
66. Salser, S. J., Loer, C. M. & Kenyon, C. Multiple HOM-C gene interactions specify cell fates in the nematode central nervous system. Genes Dev. 7, 1714-1724 (1993).
67. Kenyon, C. A gene involved in the development of the posterior body region of C. elegans. Cell 46, 477-487 (1986).
68. Ferreira, H. B., Zhang, Y., Zhao, C. & Emmons, S. W. Patterning of Caenorhabditis elegans posterior structures by the Abdominal-B homolog, egl-5. Dev. Biol. 207, 215-228 (1999).
69. Chisholm, A. Control of cell fate in the tail region of C. elegans by the gene egl-5. Development 111, 921-932 (1991).
70. Brunschwig, K. et al. Anterior organization of the Caenorhabditis elegans embryo by the labial-like Hox gene ceh-13. Development 126, 1537-1546 (1999).
71. Aboobaker, A. & Blaxter, M. Hox gene evolution in nematodes: novelty conserved. Curr. Opin. Genet. Dev. 13, 593-598 (2003). (Pubitemid 37456877)
72. Chan, S. K., Jaffe, L., Capovilla, M., Botas, J. & Mann, R. S. The DNA binding specificity of ultrabithorax is modulated by cooperative interactions with extradenticle, another homeoprotein. Cell 78, 603-615 (1994).
73. Liu, J. & Fire, A. Overlapping roles of two Hox genes and the exd ortholog ceh-20 in diversification of the C. elegans postembryonic mesoderm. Development 127, 5179-5190 (2000).
74. Liu, H., Strauss, T. J., Potts, M. B. & Cameron, S. Direct regulation of egl-1 and of programmed cell death by the Hox protein MAB-5 and by CEH-20, a C. elegans homolog of Pbx1. Development 133, 641-650 (2006).
75. Yang, L., Sym, M. & Kenyon, C. The roles of two C. elegans HOX co-factor orthologs in cell migration and vulva development. Development 132, 1413-1428 (2005).
76. Streit, A. et al. Conserved regulation of the Caenorhabditis elegans labial/Hox1 gene ceh-13. Dev. Biol. 242, 96-108 (2002).
77. Van Auken, K. et al. Roles of the Homothorax/Meis/ Prep homolog UNC-62 and the Exd/Pbx homologs CEH-20 and CEH-40 in C. elegans embryogenesis. Development 129, 5255-5268 (2002).
78. Moens, C. B. & Selleri, L. Hox cofactors in vertebrate development. Dev. Biol. 291, 193-206 (2006).
79. Potts, M. B., Wang, D. P. & Cameron, S. Trithorax, Hox, and TALE-class homeodomain proteins ensure cell survival through repression of the BH3-only gene egl-1. Dev. Biol. 329, 374-385 (2009).
80. Lohmann, I., McGinnis, N., Bodmer, M. & McGinnis, W. The Drosophila Hox gene deformed sculpts head morphology via direct regulation of the apoptosis activator reaper. Cell 110, 457-466 (2002).
81. Rogulja-Ortmann, A., Renner, S. & Technau, G. M. Antagonistic roles for Ultrabithorax and Antennapedia in regulating segment-specific apoptosis of differentiated motoneurons in the Drosophila embryonic central nervous system. Development 135, 3435-3445 (2008).
82. Faber, J. et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 11 3, 2375-2385 (2008).
83. Bernasconi, M., Remppis, A., Fredericks, W. J., Rauscher, F. J. & Schafer, B. W. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc. Natl Acad. Sci. USA 93, 13164-13169 (1996).
84. Busslinger, M., Klix, N., Pfeffer, P., Graninger, P. G. & Kozmik, Z. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl Acad. Sci. USA 93, 6129-6134 (1996).
85. Davis, R. J. et al. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum. Mol. Genet. 4, 2355-2362 (1995).
86. Epstein, J., Cai, J., Glaser, T., Jepeal, L. & Maas, R. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J. Biol. Chem. 269, 8355-8361 (1994).
87. Fredericks, W. J. et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 1522-1535 (1995).
88. Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R. & Naeve, C. W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-5112 (1993).
89. Muratovska, A., Zhou, C., He, S., Goodyer, P. & Eccles, M. R. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 7989-7997 (2003).
90. Margue, C. M., Bernasconi, M., Barr, F. G. & Schafer, B. W. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene 19, 2921-2929 (2000).
91. Gumienny, T. L., Lambie, E., Hartwieg, E., Horvitz, H. R. & Hengartner, M. O. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 126, 1011-1022 (1999).
92. Schertel, C. & Conradt, B. C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions. Development 134, 3691-3701 (2007).
93. Stergiou, L. & Hengartner, M. O. Death and more: DNA damage response pathways in the nematode C. elegans. Cell Death Differ. 11, 21-28 (2004).
94. Sendoel, A., Kohler, I., Fellmann, C., Lowe, S. W. & Hengartner, M. O. HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 465, 577-583 (2010).
95. Reddien, P. W., Andersen, E. C., Huang, M. C. & Horvitz, H. R. DPL-1 D P, LIN-35 Rb and EFL-1 E2F act with the MCD-1 zinc-finger protein to promote programmed cell death in Caenorhabditis elegans. Genetics 175, 1719-1733 (2007).
96. Milne, T. A. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107-1117 (2002).
97. Rowley, J. D. The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36, 59-72 (1999).
98. Ernst, P., Wang, J. & Korsmeyer, S. J. The role of MLL in hematopoiesis and leukemia. Curr. Opin. Hematol. 9, 282-287 (2002).
99. Krivtsov, A. V. & Armstrong, S. A. MLL translocations, histone modifications and leukaemia stem-cell development. Nature Rev. Cancer 7, 823-833 (2007).
100. Armstrong, S. A. et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genet. 30, 41-47 (2002).
101. Grimwade, D. et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92, 2322-2333 (1998).
102. Moorman, A. V. et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109, 3189-3197 (2007).
103. Biondi, A., Cimino, G., Pieters, R. & Pui, C. H. Biological and therapeutic aspects of infant leukemia. Blood 96, 24-33 (2000).
104. Pui, C. H., Relling, M. V. & Downing, J. R. Acute lymphoblastic leukemia. N. Engl. J. Med. 350, 1535-1548 (2004).
105. Mancini, M. et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 105, 3434-3441 (2005).
106. Bijl, J. et al. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood 108, 116-122 (2006).
107. Lawrence, H. J. et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89, 1922-1930 (1997).
108. Ko, K. H. et al. Hoxb3 deficiency impairs B lymphopoiesis in mouse bone marrow. Exp. Hematol. 35, 465-475 (2007).
109. Magnusson, M., Brun, A. C., Lawrence, H. J. & Karlsson, S. Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects. Exp. Hematol. 35, 1421-1428 (2007).
110. Brun, A. C. et al. Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 103, 4126-4133 (2004).
111. Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818-822 (2006).
112. Wong, P., Iwasaki, M., Somervaille, T. C., So, C. W. & Cleary, M. L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21, 2762-2774 (2007).
113. Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257-268 (2006).
114. Kumar, A. R. et al. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood 103, 1823-1828 (2004).
115. Ayton, P. M. & Cleary, M. L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17, 2298-2307 (2003).
116. Schnabel, C. A., Jacobs, Y. & Cleary, M. L. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 19, 608-616 (2000).
117. Hunger, S. P., Ohyashiki, K., Toyama, K. & Cleary, M. L. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 6, 1608-1620 (1992).
118. Seidel, M. G. & Look, A. T. E2A-HLF usurps control of evolutionarily conserved survival pathways. Oncogene 20, 5718-5725 (2001).
119. Beachy, P. A., Karhadkar, S. S. & Berman, D. M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331 (2004).
120. Curran, T. & Ng, J. M. Cancer: Hedgehog's other great trick. Nature 455, 293-294 (2008).
121. Eklund, E. A. The role of HOX genes in malignant myeloid disease. Curr. Opin. Hematol. 14, 85-89 (2007).
122. Argiropoulos, B., Yung, E. & Humphries, R. K. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev. 21, 2845-2849 (2007).
123. Abramovich, C. & Humphries, R. K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr. Opin. Hematol. 12, 210-216 (2005).
124. Grier, D. G. et al. The pathophysiology of HOX genes and their role in cancer. J. Pathol. 205, 154-171 (2005).
125. Mercado, G. E. & Barr, F. G. Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances. Curr. Mol. Med. 7, 47-61 (2007).
126. Colleypriest, B. J., Palmer, R. M., Ward, S. G. & Tosh, D. Cdx genes, inflammation and the pathogenesis of Barrett's metaplasia. Trends Mol. Med. 15, 313-322 (2009).
127. Bansal, D. et al. Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model. Proc. Natl Acad. Sci. USA 103, 16924-16929 (2006).
128. Guo, R. J., Suh, E. R. & Lynch, J. P. The role of Cdx proteins in intestinal development and cancer. Cancer Biol. Ther. 3, 593-601 (2004).
129. Bany, I. A., Dong, M. Q. & Koelle, M. R. Genetic and cellular basis for acetylcholine inhibition of Caenorhabditis elegans egg-laying behavior. J. Neurosci. 23, 8060-8069 (2003).